(1)
Perletti, G. Reply To: Clarification to Provide Further Understanding of the Conduct and Design of TROPIC: A Phase 3 Trial of Cabazitaxel Versus Mitoxantrone in Patients With Metastatic Castration-Resistant Prostate Cancer. AIUA 2016, 88, 74-75.